Merck & Co., Inc: all 2,453 studies
Page 11 of 25. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- Pharmacokinetics of Suvorexant in Participants With Impaired Renal Function (MK-4305-023)(COMPLETED)CompletedNCT01059851Phase 1Results posted
- Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)CompletedNCT01059825Phase 2Results posted
- Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic NeuralgiaTerminatedNCT01058642Phase 2Results posted
- Observational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2)CompletedNCT01054742Results posted
- Effects of Once and Twice Daily Dosing Regimen of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-040)CompletedNCT01054300Phase 1Results posted
- Comparison of Sugammadex With Neostigmine as Reversal Agents for Rocuronium at Reappearance of T2 (Study P06101)CompletedNCT01050543Phase 3Results posted
- Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)CompletedNCT01048671Results posted
- A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)CompletedNCT01047345Phase 3Results posted
- A Dose Escalation Study of Adavosertib(MK1775) in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005TerminatedNCT01047007Phase 1Results posted
- Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)TerminatedNCT01045798Phase 2Results posted
- Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017)CompletedNCT01043926Phase 1Results posted
- A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)CompletedNCT01034111Phase 3Results posted
- A Multiple Dose Study of MK-3614 (MK-3614-002)CompletedNCT01033643Phase 1Results posted
- 30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)CompletedNCT01028391Phase 3Results posted
- Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED)CompletedNCT01026831Phase 3Results posted
- Safety and Tolerability of MK-5478 in Participants With Hypertension (5478-001)CompletedNCT01025843Phase 1Results posted
- A Single Dose Study of MK-8266 (MK-8266-001)CompletedNCT01025791Phase 1Results posted
- Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2)CompletedNCT01023035Phase 3Results posted
- Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011)CompletedNCT01021852Phase 2Results posted
- A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3)CompletedNCT01021813Phase 3Results posted
- A Combination Therapy Study of MK-2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010)CompletedNCT01021748Phase 1Results posted
- A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)TerminatedNCT01015677Phase 2Results posted
- 18F-FLT-PET in Breast Cancer (MK-0000-139)CompletedNCT01015131Phase 2Results posted
- Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055)CompletedNCT01014013Phase 3Results posted
- A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)CompletedNCT01012219Phase 1Results posted
- A Study Investigating the Influence of Hepatic Insufficiency on the Pharmacokinetics of Vaniprevir (MK-7009-005)CompletedNCT01010906Phase 1Results posted
- Long-Term Study of the Effects of Navarixin (SCH 527123, MK-7123) in Participants With Moderate to Severe COPD (MK-7123-019)TerminatedNCT01006616Phase 2Results posted
- A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)CompletedNCT01000818Phase 1Results posted
- A Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Male Participants (MK-5172-004)CompletedNCT00998985Phase 1Results posted
- MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)CompletedNCT00996801Phase 2Results posted
- Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202)CompletedNCT00993187Phase 4Results posted
- A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012)CompletedNCT00990821Phase 1Results posted
- A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)CompletedNCT00988884Phase 3Results posted
- An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066)CompletedNCT00988832Results posted
- Sugammadex Hypersensitivity Study (Study P06042)CompletedNCT00988065Phase 1Results posted
- ProQuad Dose Selection Study (V221-011)(COMPLETED)CompletedNCT00986232Phase 2Results posted
- A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)CompletedNCT00985166Phase 3Results posted
- Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)CompletedNCT00985153Phase 3Results posted
- Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)TerminatedNCT00984568Phase 3Results posted
- Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric VaccinesCompletedNCT00984295Phase 3Results posted
- Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the KneeCompletedNCT00979953Phase 2Results posted
- A Study of the Pharmacokinetics of Two Formulations of MK-1006 (MK-1006-010 AM1)(COMPLETED)CompletedNCT00979459Phase 1Results posted
- ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)CompletedNCT00975507Phase 3Results posted
- Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)CompletedNCT00975130Phase 3Results posted
- Bioequivalence of Two Formulations of Ondansetron in Healthy Adults (0869-106)CompletedNCT00972595Phase 1Results posted
- Pharmacokinetics and Pharmacodynamics of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012)CompletedNCT00972322Phase 1Results posted
- A Bioequivalence Study of 3 Formulations of Ondansetron in Healthy Adults (0869-095)(COMPLETED)CompletedNCT00971633Phase 1Results posted
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002)TerminatedNCT00968617Phase 2Results posted
- A Study of MK-2206 in Combination With Trastuzumab and Lapatinib for the Treatment of HER2+ Solid Tumors (MK-2206-015)TerminatedNCT00963547Phase 1Results posted
- A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant [MK0524A]) in Patients With Dyslipidemia (0524A-102)CompletedNCT00961636Phase 3Results posted
- A Dose-Ranging Study of MK-5442 in Postmenopausal Women With Osteoporosis (MK-5442-001)TerminatedNCT00960934Phase 2Results posted
- A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)TerminatedNCT00960063Phase 1Results posted
- A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)CompletedNCT00959699Phase 2Results posted
- Pharmacokinetics of Vaniprevir (MK-7009) and Hepatitis C Virus RNA Levels After Vaniprevir Treatment (MK-7009-029)TerminatedNCT00954993Phase 1Results posted
- Safety, Radiation Dosimetry, Biokinetics, and Effectiveness of [18F]MK3328 (MK-3328-001)CompletedNCT00954538Phase 1Results posted
- Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)TerminatedNCT00954512Phase 1/2Results posted
- A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)CompletedNCT00953056Phase 1Results posted
- Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)CompletedNCT00952341Phase 3Results posted
- A Study to Assess the Bioequivalence of Famotidine Chewable Tablets and Film-Coated Tablets (0208-144)CompletedNCT00945750Phase 1Results posted
- A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165)CompletedNCT00945321Phase 1Results posted
- MK0524A Bioequivalence Study (0524A-059)CompletedNCT00944645Phase 1Results posted
- Study of the Bioequivalence of Two Tablet Forms of MK0431 (0431-027)CompletedNCT00944450Phase 1Results posted
- A Study of Vaniprevir (MK-7009) in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028)CompletedNCT00943761Phase 2Results posted
- A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)CompletedNCT00943722Phase 3Results posted
- MK0524B Bioequivalence Study (0524B-070)CompletedNCT00943124Phase 1Results posted
- Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)CompletedNCT00941603Phase 2Results posted
- Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED)CompletedNCT00935259Phase 1Results posted
- Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)TerminatedNCT00931606Phase 2Results posted
- Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)CompletedNCT00929201Phase 1Results posted
- Fenofibrate Bioequivalence Study (0767-031)CompletedNCT00928694Phase 1Results posted
- Phase I Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Participants With Colorectal Cancer (MK-0646-016)CompletedNCT00925015Phase 1Results posted
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12)TerminatedNCT00924781Phase 2Results posted
- Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract InfectionsCompletedNCT00921024Phase 2Results posted
- A Study of Absorption, Metabolism, Excretion and Mass Balance After a Single Dose Administration of MK-0941 (MK-0941-016)(COMPLETED)CompletedNCT00912002Phase 1Results posted
- Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin (P05514)CompletedNCT00910624Phase 3Results posted
- The OBSTACLE Hypoglycemia Study (MK-0000-158)CompletedNCT00907881Results posted
- A Continuation Clinical Trial of Oral Vorinostat (MK-0683) in Advanced Cancers (MK-0683-007)CompletedNCT00907738Phase 2Results posted
- Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247)TerminatedNCT00907517Phase 1Results posted
- A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED)CompletedNCT00902161Phase 1Results posted
- Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED)CompletedNCT00896233Phase 1Results posted
- Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac SurgeryCompletedNCT00888940Phase 2Results posted
- MK0954 Versus Placebo for Treatment of Mild to Moderate HypertensionCompletedNCT00888355Phase 3Results posted
- A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)CompletedNCT00888238Phase 1Results posted
- A Study to Investigate the Antihypertensive Efficacy of MK0954CompletedNCT00887250Phase 3Results posted
- A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)CompletedNCT00886613Phase 1Results posted
- A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)CompletedNCT00886600Phase 3Results posted
- Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)CompletedNCT00885352Phase 3Results posted
- A Study to Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (MK-0822-042)CompletedNCT00885170Phase 2Results posted
- Study to Evaluate Daptomycin Given During Dialysis and After DialysisCompletedNCT00882557Phase 1Results posted
- A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)CompletedNCT00882440Phase 3Results posted
- A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016)CompletedNCT00880763Phase 2Results posted
- Phase I Study of MK-1496 in Patients With Advanced Solid Tumor (MK-1496-002 AM 4)(COMPLETED)CompletedNCT00880568Phase 1Results posted
- Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)CompletedNCT00875394Phase 3Results posted
- Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103)CompletedNCT00875056Phase 2Results posted
- A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)TerminatedNCT00874939Phase 1Results posted
- A Study to Evaluate the Effect of MK-8669 (Ridaforolimus) on QTc Interval in Participants With Advanced Cancer (MK-8669-037)CompletedNCT00874731Phase 1Results posted
- A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)CompletedNCT00873821Phase 1Results posted
- The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)TerminatedNCT00872001Phase 3Results posted
- Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed)CompletedNCT00871871Phase 1Results posted
- A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)TerminatedNCT00868790Phase 2Results posted